Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Oral ketamine reduces the experience of stress in people with chronic suicidality.
J Affect Disord. 2022 Mar 1;300:410-417. doi: 10.1016/j.jad.2022.01.018. Epub 2022 Jan 10.
J Affect Disord. 2022.
PMID: 35016117
Relationships between reduction in symptoms and restoration of function and wellbeing: Outcomes of the Oral Ketamine Trial on Suicidality (OKTOS).
Beaudequin D, Can AT, Jones M, Yang C, Scherman JK, Dutton M, Schwenn P, Forsyth CGG, Jensen E, Hermens DF, Lagopoulos J.
Beaudequin D, et al. Among authors: scherman jk.
Psychiatry Res. 2021 Nov;305:114212. doi: 10.1016/j.psychres.2021.114212. Epub 2021 Sep 20.
Psychiatry Res. 2021.
PMID: 34563973
Clinical Trial.
Item in Clipboard
Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study.
Can AT, Hermens DF, Dutton M, Gallay CC, Jensen E, Jones M, Scherman J, Beaudequin DA, Yang C, Schwenn PE, Lagopoulos J.
Can AT, et al.
Transl Psychiatry. 2021 Feb 4;11(1):101. doi: 10.1038/s41398-021-01230-z.
Transl Psychiatry. 2021.
PMID: 33542187
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite